Zai Lab Ltd (HK:9688) has released an update. Zai Lab Limited has announced a proposed follow-on underwritten public offering of $200 million in American depositary shares in the United States ...
Zai Lab Ltd (HK:9688) has released an update. Zai Lab Ltd, a biopharmaceutical company, announced a proposed $200 million follow-on public offering of American Depositary Shares (ADSs) to support ...
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ: ZLAB; HKEX: 9688), an innovative, commercial-stage biopharmaceutical company, today announced the ...